1. Home
  2. IOSP vs KYMR Comparison

IOSP vs KYMR Comparison

Compare IOSP & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOSP
  • KYMR
  • Stock Information
  • Founded
  • IOSP 1938
  • KYMR 2015
  • Country
  • IOSP United States
  • KYMR United States
  • Employees
  • IOSP N/A
  • KYMR N/A
  • Industry
  • IOSP Major Chemicals
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • IOSP Industrials
  • KYMR Health Care
  • Exchange
  • IOSP Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • IOSP 2.6B
  • KYMR 2.2B
  • IPO Year
  • IOSP 1998
  • KYMR 2020
  • Fundamental
  • Price
  • IOSP $95.20
  • KYMR $29.62
  • Analyst Decision
  • IOSP
  • KYMR Buy
  • Analyst Count
  • IOSP 0
  • KYMR 13
  • Target Price
  • IOSP N/A
  • KYMR $56.69
  • AVG Volume (30 Days)
  • IOSP 343.9K
  • KYMR 597.4K
  • Earning Date
  • IOSP 05-08-2025
  • KYMR 05-01-2025
  • Dividend Yield
  • IOSP 1.63%
  • KYMR N/A
  • EPS Growth
  • IOSP N/A
  • KYMR N/A
  • EPS
  • IOSP 1.42
  • KYMR N/A
  • Revenue
  • IOSP $1,845,400,000.00
  • KYMR $47,072,000.00
  • Revenue This Year
  • IOSP $5.02
  • KYMR $44.93
  • Revenue Next Year
  • IOSP $7.22
  • KYMR N/A
  • P/E Ratio
  • IOSP $67.04
  • KYMR N/A
  • Revenue Growth
  • IOSP N/A
  • KYMR N/A
  • 52 Week Low
  • IOSP $94.77
  • KYMR $29.07
  • 52 Week High
  • IOSP $133.71
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • IOSP 35.88
  • KYMR 33.94
  • Support Level
  • IOSP $96.88
  • KYMR $29.83
  • Resistance Level
  • IOSP $99.48
  • KYMR $35.28
  • Average True Range (ATR)
  • IOSP 2.46
  • KYMR 1.79
  • MACD
  • IOSP 0.22
  • KYMR -0.20
  • Stochastic Oscillator
  • IOSP 5.74
  • KYMR 4.54

About IOSP Innospec Inc.

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The fuel specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field services providers in the extraction of oil and gas. The performance chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: